ClinVar Miner

Submissions for variant NM_001370658.1(BTD):c.41_44del (p.Gly14fs)

dbSNP: rs1249246307
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Illumina Laboratory Services, Illumina RCV000778682 SCV000915025 uncertain significance Biotinidase deficiency 2018-10-29 criteria provided, single submitter clinical testing The BTD c.101_104delGCTG (p.Gly34ValfsTer35) variant is a frameshift variant that is predicted to result in an absent or truncated protein. A literature search for the gene, cDNA change, and protein change did not reveal any clinical reports of this variant in individuals with biotinidase deficiency. In a retrospective analysis of carrier screening in 17638 chromosomes from ethnically diverse populations, Haque et al. (2016) identified the p.Gly34ValfsTer35 variant in one Caucasian allele. The variant is also reported at a frequency of 0.000363 in the European American population of the Exome Sequencing Project. Based on the potential impact of frameshift variants and the lack of clarifying evidence, the p.Gly34ValfsTer35 variant is classified as a variant of unknown significance but suspicious for pathogenicity for biotinidase deficiency. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.
CeGaT Center for Human Genetics Tuebingen RCV001090471 SCV001246038 pathogenic not provided 2018-12-01 criteria provided, single submitter clinical testing
Invitae RCV000778682 SCV001587423 pathogenic Biotinidase deficiency 2023-10-24 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Gly34Valfs*35) in the BTD gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in BTD are known to be pathogenic (PMID: 20083419). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with biotinidase deficiency (PMID: 7550325, 27657684, 27845546, 28220409; Invitae). ClinVar contains an entry for this variant (Variation ID: 631911). For these reasons, this variant has been classified as Pathogenic.
Arcensus RCV000778682 SCV002564587 likely pathogenic Biotinidase deficiency 2013-02-01 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.